BIOTECHNOLOGY & LIFE SCIENCES

Similar documents
BIOTECHNOLOGY & LIFE SCIENCES

The state of Kansas has two workforce training programs to offset a company's training costs:

BIOHEALTH INDUSTRY. Start Your Career in Wisconsin s BIOTECH AND BIOPHARMA MEDICAL DEVICE AND DIAGNOSTICS HEALTH RESEARCH INSTITUTES BIO- MANUFACTURE

Promoting the Biotechnology Industry in Germany

BIOHEALTH INDUSTRY. Start Your Career in Wisconsin s BIOTECH AND BIOPHARMA MEDICAL DEVICE AND DIAGNOSTICS HEALTH RESEARCH INSTITUTES BIO- MANUFACTURE

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.

BIOLOGICS & PROCESS TECHNOLOGY MASTER CLASS

Investor Presentation. September 2018

Food and Drug Administration (FDA) 101

TECHNOLOGY READINESS LEVELS (TRLs)

Orphan Medicinal Products

Trans-omics for a better life

Investor presentation. December 2018

ADDRESS BY H.R.H. PRINCE PHILIPPE OF BELGIUM BIO CONVENTION WASHINGTON

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September

Greenwood Genetic Center

One ecosystem. 360 opportunities.

Evogene - Bayer CropScience Multi-year Collaboration to Improve Wheat Seed. December 13, 2010

Our job today Enlist you to help us cross the Translational Divide between the lab bench and the patient s bedside Demonstrate that this will

- OMICS IN PERSONALISED MEDICINE

Business and Industry Advisory Committee to the OECD - Comité Consultatif Economique et Industriel Auprès de l OCDE

Introducing the Department of Life Sciences

to acquire Investor And Analyst Call Presentation January 4, 2008

Bioinformatics Specialist

Centre for NanoHealth

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

Job Title: Cell Culture Technician (open June 1 through Oct 31, 2016)

TAIWAN. Who Should Attend? Endless Potential & Opportunities. Where innovations are shaping a new era of intelligent healthcare.

Yield10 Bioscience, Inc.

SMEs in IMI2 Calls for Proposals

Orthopaedic Innovation: Bench, Bedside, Bank

Pioneering Clinical Omics

Konica Minolta to Acquire Invicro (US)

Innovations in Molecular Lab Operation. Joseph M. Campos, PhD, D(ABMM), F(AAM)

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

LEGISLATIVE AGENDA. North Myrtle Beach Chamber of Commerce Local Legislative Agenda PUBLIC POLICY COUNCIL GOAL:

Regulatory requirements for cell based medicinal products

The Economic Contributions of the Biotechnology Industry to the U.S. Economy

To meet the challenge of providing safe, cost-effective medicines for the world s largest

Overview and Status Update

Happy 30 th Birthday DBT!!

The Essential Guide To Managing Biotech Labs

LEGISLATIVE AGENDA. North Myrtle Beach Chamber of Commerce Local Legislative Agenda PUBLIC POLICY COUNCIL GOAL:

NHS ENGLAND BOARD PAPER

Micar Innovation. Drug Discovery Factory for novel drug molecules

National Health Research Institutes

Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA

Basic Concepts and History of Genetic Engineering. Mitesh Shrestha

Practice Optimization Package:

OUR MISSION OUR EXPERTISE OUR SERVICES

How Targets Are Chosen. Chris Wayman 12 th April 2012

INTERNATIONAL COLLABORATION. S. Sinha Adviser Department of Biotechnology Ministry of Science & Technology Government of India

Life Sciences Debashis Ghosh. 1 Copyright 2016 Tata Consultancy Services Limited

GENERAL PAYER CONSIDERATIONS FOR NEW HEALTH TECHNOLOGIES (INCLUDING DIAGNOSTICS)

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)

Table of Contents. Abbreviations and Acronyms Preface Executive Summary... 15

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

Isolation, purification, culturing and cryopreservation of primary cells from human samples

Visit our Career Flowchart to get more information on some of these career paths.

Clinical and Translational Bioinformatics

STRATEGY FOR UK BIOTECHNOLOGY AND BIOLOGICAL SCIENCES INVITATION TO COMMENT. Introduction

social, and population-based research conducted and supported by the National Institutes of Health (NIH). The

2007/SOM1/HLPDAB/022 Investment Toolbox Malaysian Biotech Corporation s Investment Toolbox: A Case Study

at a glance Lugano, 20 September 2013 LUGANO SMALL & MID CAP INVESTOR DAY > 50 years of Pharmaceutical & Life Science Services IV Edizione

Overview of Biotechnology in Thailand

NORDP Research Development Conference Research Development Strategy: Designing a De Novo Institute With Numerous Degrees of Freedom

Precision Medicine. Presented by:

State of Washington s Life Sciences Sector. Chris E. Rivera President, WBBA

Trends in Biotechnology Investment

Small Scale Bio-Manufacturing for Clinical Trails; an Introduction to the Clinical Biotechnology Centre

Valuing Healthcare Biotechnology in Europe: EuropaBio s perspective

Novartis Business Services HR University Relations. Chemical and Analytical Development. Early Talent Program

Why Culture Matters in Cancer Research

AKESOgen, Inc, 3155 Northwoods Place, NW, Norcross, GA 30071, USA Tel: +1 (770) Page 1

Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis

HOW TO CREATE AN ENTRY-LEVEL CERTIFICATE FROM CORE BIOSCIENCE SKILL STANDARDS NATIONAL CAREER PATHWAYS NETWORK ANNUAL CONFERENCE

Engage with us on Twitter: #Molecule2Miracle

First Quarter Trusted by the Life Sciences Industry

PLACEMENT BROCHURE 17-18

WuXi PharmaTech: Building an Open-Access Capability and Technology Platform. Jefferies Healthcare Conference November 2014

Human Genome Editing: Science, Ethics, and Governance Highlights for Industry Stakeholders

Utrecht Region. A key role in the Netherlands pharma/ biotech industries. Why locate your pharma/ biotech company in the Utrecht Region?

The Biotechnology Industry in Taiwan

GREENPRINT TO BREAKTHROUGH RESEARCH

34 th Annual J.P. Morgan Healthcare Conference

BIOTECHNOLOGY CENTER FOR A NEWYORK STATE CENTER FOR ADVANCED TECHNOLOGY

Evaluation and Regulation of Biomarkers A Public Health Perspective

Konica Minolta to Acquire Ambry Genetics (US)

AG RESEARCH AT PURDUE. People. Making an Impact

Physiomics Plc. ("Physiomics" or "the Company") Interim Results Statement for the six month period ended 31 December 2015

GENOMICS HEALTH FUTURES MISSION

Greater rewards. Fewer complications.

From Discovery to Development of new Drugs. and pitfalls along the way. by Kim Dekermendjian, PhD in Medicine BD & Key Account manager

APS Science Curriculum Unit Planner

Clusters as a tool for Innovation at the University of Debrecen. Prof. Dr. József Tőzsér Deputy Rector, University of Debrecen

PATHWAY TO VALUE CREATION NASDAQ: BNTC ASX: BLT

PATHWAY TO VALUE CREATION NASDAQ: BNTC ASX: BLT. For personal use only

SUPPLEMENT TO THE GOVERNMENT S BUDGETARY POLICY ACTION. Support for the Biotechnology Sector

Yield10 Bioscience, Inc.

Transcription:

BIOTECHNOLOGY & LIFE SCIENCES

SOUTH DAKOTA BIOTECHNOLOGY & LIFE SCIENCES Entrepreneurs, small businesses and large corporations alike find that South Dakota is a great place for bioscience businesses. We have a bioscience infrastructure that includes cgmp facilities, research parks, full Laboratory Animal Research Facility and world-class health care systems. Our small size lends opportunities for collaboration that you don t find in every state. South Dakota also has a skilled and ready workforce and one of the top business climates in the nation. ANIMAL & AGRICULTURE BIOTECH BIOFUELS RESEARCH & DEVELOPMENT ANIMAL & AGRICULTURE BIOTECH In South Dakota, we have a unique intersection of agriculture and biosciences. Whether your focus is animal medicine and vaccines, high value feed additives, plant biotech, functional foods and additives or transgenic animals, South Dakota is a great fit. BIOFUELS Major players in the world of biofuels call South Dakota home. Our agriculture-based economy lays the groundwork for biofuel and ethanol companies like POET and Glacial Lakes Energy to thrive in South Dakota. 2

RESEARCH & DEVELOPMENT CAPABILITIES Whether you re a startup company or established business looking to expand or relocate, we have all the resources you need at your fingertips. South Dakota R&D capabilities include pilot-scale cgmp and GMP facilities, small and large animal research facilities, wet labs and dry labs, as well as office space. BIOSNTR BioSNTR (Biosystems Networks & Translational Research) is a state-of-the-art imaging and informatics distributed research initiative with more than 30 affiliated researchers from universities and research institutions in South Dakota. BioSNTR capabilities include: z Pilot-scale GMP facility, greenhouse and field testing z Large and small animal research facilities z Gene editing, assay development, cell sorting and compound screening z Imaging cell populations in vivo, molecules within cells, cells within tissues and molecular imaging in plants z High performance computing RESEARCH PARK AT SOUTH DAKOTA STATE UNIVERSITY Located on 125 acres, the Innovation Campus Research Park at South Dakota State University will provide more than one million square feet of first-class office space, laboratories, conference rooms and greenhouse space. CLINICAL RESEARCH & RESEARCH COLLABORATION: South Dakota is home to two top-ranked hospital systems. Cutting-edge research and development at Sanford Health and Avera Health are taking aim at some of the world s most difficult diseases. SANFORD RESEARCH Sanford Research is comprised of several research centers, including Children s Health Research, Edith Sanford Breast Cancer, Cancer Biology, Center for Health Outcomes and Prevention, and Sanford Sports Science Institute. The goal of Sanford Research is to become one of the premiere research institutions in the United States and world. The Sanford Research Center has a full Laboratory Animal Research Facility (LARF) which enables the ethical, humane use of laboratory animals for research. The facility is registered with the United States Department of Agriculture (USDA), and the facility is inspected by the USDA/APHIS. GEAR CENTER The 22,000 sq. ft. USD Graduate Education and Applied Research (GEAR) Center provides a physical location for both private sector and university research activities. GEAR Center capabilities: z Aseptic GMP Production and Training center provides pilot-scale cgmp services z Specialized research suites, equipment and technical staff available to support public and private sector research activities USD DISCOVERY DISTRICT The 80-acre USD Discovery District is a dynamic and collaborative environment where talent, research, and innovative businesses interact to create new ideas, new technologies and new opportunities impacting the region and our world. When complete, the district will include more than 1 million sq. ft. of lab, production, science and technology, commercial and retail space. AVERA RESEARCH INSTITUTE At Avera, they re using innovation and research to stay ahead of the curve in light of a changing environment, and changing consumer demands. Since 1998, the Avera Research Institute has been a place where health care innovations are developed and tested. The Avera Institute for Human Genetics (AIHG) is a state-ofthe-art molecular genetics laboratory with the capability to undertake a wide range of projects from small-scale pilot candidate gene projects to large-scale high throughput genome-wide association studies on tens of thousands of samples. The AIHG scientific lab houses cutting-edge genetics laboratory equipment enabling researchers to describe a patient s genetic profile. 3

WORKFORCE BIOSCIENCE GRADUATES In South Dakota, 6,356 Individuals graduated with a degree in the biosciences in the last five years from the public university system. DEGREE PROGRAMS South Dakota s public university system offers more than 78 degree programs in the biosciences. BIO DEGREES 19 PERCENT of South Dakota public university graduates earn a degree in the biosciences INCENTIVES & FINANCING In South Dakota, we re fortunate to work cooperatively in a business climate that s second to none. Whether you re just laying the ground work or you ve been around for a while, no matter your company s size, South Dakota s economic development team is ready to partner with you. The Governor s Office of Economic Development offers an array of financing to meet the long-term and short-term needs of new and growing businesses. Whether it is working capital or fixed-asset purchases, our programs are designed with businesses in mind. PROOF OF CONCEPT FUND: z Provides up to $25,000 to conduct research demonstrating the technical and economic feasibility of an innovation z Eligible applicants include: entrepreneurs, universities, existing South Dakota companies, or other entities committed to commercializing the results in South Dakota z Requires a matching cash or in-kind investment of at least 10% of the total cost z Investment proceeds may be used to pay consultant contracts, materials and supplies, salaries for employees in South Dakota, and necessary services for technical feasibility or marketing studies NEW FRONTIERS: z Assists companies in offsetting R&D costs, such as clinical trial costs, associated with gaining regulatory approval of products z Companies can apply for reimbursement of sales tax associated with R&D and testing expenditures z R&D plan and projected expenditures must be submitted with application SOUTH DAKOTA EQUITY PARTNERS: The Governor s Office of Economic Development works closely with South Dakota Equity Partners, a private equity investment fund that targets early and growth-stage companies that need capital to support entry into the market, expansion and development plans in South Dakota. TAX CLIMATE In South Dakota, businesses pay fewer taxes, often at lower rates, than in other states across the country. The South Dakota business person enjoys: z No Corporate Income Tax z No Personal Income Tax z No Personal Property Tax z No Business Inventory Tax z No Inheritance Tax REGULATORY CLIMATE South Dakota boasts a reasonable and deliberate regulatory environment. When permitting, responses are quick, and government leaders are continually working to eliminate unnecessary and outdated laws that create additional red tape. 4

FOR MORE INFORMATION: Contact Kristen Honey, GOED s Business Development Representative in the bioscience industry. kristen.honey@sdreadytowork.com 605-367-4301 www.sdreadytowork.com/bioscience